Immunomodulating fungal and plant polysaccharides; biochemistry, immunologic activity and clinical application

Journal of Traditional Medicines

Volumn 21, Issue 2, 2004, Pages 67-80

  Lee, Chi jen ^a   Lee, Lucia H ^a   Huo, Yu Shuh ^b   Cheng hsiung, Lu ^c   Koizumi, Kaio ^d  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^d Tsukuba Institute of Environmental Microbiology   (Japan)

Author keywords

activation of macrophage; cell mediated immunity; cytokine induction; fungal and plant polysaccharides; immunostimulating and antitumor activities; structure activity relationship

Indexed keywords

EID: 85009583590     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.21.67     Document Type: Article

References (112)

1. Lee, C.J. : Resurgence of Oriental medicine. In Managing Biotechnology in Drug Development, CRC Press, Inc., Boca Raton, FL., pp. 118-126, 1996.
2. Chihara, G., Hamuro, J., Maeda, Y., Aria, Y., Fukuoka, F.: Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res., 30, 2776-2781, 1970.
3. Chihara, G., Maeda, Y., Hamuro, J., Sasaki, T., Fukuoka, F.: Inhibition of mouse sarcoma 180 by polysaccharide from Lentinus edodes (Berk.) Sing. Nature 222, 687-688, 1969.
4. Chihara, G, Hamuro, J., Maeda, Y., Arai, Y., Fukuoka, F.: Antitumor polysaccharide derived chemically from natural glucan (Pachyman). Nature 225, 943-944, 1970.
5. Lien, E.J.: Fungal metabolites and Chinese herbal medicine as immunostimulants. Prog. Drug Res., 34, 395-420, 1990.
6. Bluhm, T.L., Sarko, A.: The triple helical structure of lentinan, a linear β-(1-3)-D-glucan. Can J. Chem., 55, 293-299, 1977.
7. Moriyuki, H., Ichimura, M.: Acute toxicity of lentinan in mice and rats. J. Toxicol. Sci., 5 Suppl, 1-9, 1980.
8. Chihara, G.: Preclinical evaluation of lentinan in animal models. Adv. Exp. Med. Biol., 166, 189-197, 1983.
9. Li, J.F., Guo, J.W., Huang, X.F.: Study on the enhancing effect of polyporus polysaccharide, mycobacterium polysaccharide and lentinan on lymphokine-activated killer cell activity in vitro. Chin. J. Integr. Trad. West. Med., 16, 224-226, 1996.
10. Liu, F., Ooi, V.E., Fung, M.C.: Analysis of immunomodulating cytokine mRNAs in the mouse induced by mushroom polysaccharides. Life Sci., 64, 1005-1011, 1999.
11. Suzuki, M., Kikuchi, T., Takatsuki, F., Hamuro, J.: Curative effects of combination therapy with lentinan and inteleukin-2 against established murine tumors, and the role of CD-8 positive T cells. Cancer Immunol. Immunother., 38, 1-8, 1994.
12. Ogawa, T., Ohwada, S., Sato, Y., Izumi, M., Nakamura, S., Takeyashi, I.: Effects of 5′-DFUR and Lentinan on cytokines and PyNPase against AH66 ascites hepatoma in rats. Anticancer Res., 19, 375-380, 1999.
13. Nakano, H., Namatame, K., Nemoto, H., Motohashi, H., Nishiyama, K., Kumada, K.: A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Hepatogastroenterology 46, 2662-2668, 1999.
14. Taguchi, T.: Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey. Cancer Detect. Prev. Suppl., 1, 333-349, 1987.
15. Arinaga, S., Krimine, N., Takamuku, K., Nanbara, S., Nagamatsu, M., Ueo, H., Akiyoshi, T.: Enhanced production of interleukin 1 and tumor necrosis factor by peripheral monocytes after lentinan administration in patients with gastric carcinoma. Int. J. Immunopharmacol., 14, 43-47, 1992.
16. Arinaga, S., Karimine, N., Takamuku, K., Nanbara, S., Inoue, H., Nagamatsu, M., Ueo, H., Akiyoshi, T.: Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma. Int. J. Immunopharmacol., 14, 535-539, 1992.
17. Ng, T.B.: A review of research on the protein-bound polysaccharide (polysaccharide, PSP) from the mushroom Coriolus versicolor (basidomycetes: polyporaceae). Gen. Pharmac., 30, 1-4, 1998.
18. Tsukagoshi, S., Hashimoto, Y., Fujii, G., Kobayashi, H., Nomoto, K., Orita, K.: Krestin (PSK). Cancer Treat. Rev., 11, 131-155, 1984.
19. Wang, H.X., Ng, T.B., Liu, W.K., Ooi, V.E., Chang, S.T.: Polysaccharide-peptide complexes from the cultured mycelia of the mushroom Coriolus versicolor and their culture medium activate mouse lymphocytes and macrophages. Int. Biochem. Cell Biol., 28, 601-607, 1996.
20. Kidd, P.M.: The use of mushroom glucans and proteoglycans in cancer treatment. Altern. Med. Rev., 5, 4-27, 2000.
21. Fisher, M. and Yang, L.X.: Anticancer effects and mechanisms of polysaccharide-K (PSK): Implications of cancer immunotherapy. Anticancer Res., 22, 1737-1754, 2002.
22. Pang, Z.J., Chen, Y., Zhow, M., Wan, J.: Effect of polysaccharide krestin on glutathione peroxidase gene expression in mouse peritoneal macrophages. Br. J. Biomed. Sci., 57, 130-136, 2000.
23. Pang, Z.J., Chen, Y., Zhou, M.: Polysaccharide Krestin enhances manganese superoxide dismutase activity and mRNA expression in mouse peritoneal macrophages. Am. J. Chin. Med., 28, 331-341, 2000.
24. Asai, K., Kato, H., Hirose, K., Akaogi, K., Kimura, S., Mukai, S., Inoue, M., Yamamura, Y., Sano, H., Sugino, S., Yoshikawa, T., Kondo, M.: PSK and OK-432-induced immunomodulation of inducible nitric oxide (NO) synthase gene expression in mouse peritoneal polymorphonuclear leukocytes and NO-mediated cytotoxicity. Immunophoarcol. Immunotoxicol., 22, 221-235, 2000.
25. Liu, W.K., Ng, T.B., Szu, S.F., Tsui, K.W.: Activation of peritoneal macrophages by polysaccharide from the mushroom, Coriolus versicolor. Immunopharmacology 26, 139-146, 1993.
26. Qian, Z.M., Xu, M.F., Tang, P.L.: Polysaccharide peptide (PSP) restores immunosusppression induced by cyclophosphamide in rats. Am. J. Chin. Med., 25, 27-35, 1997.
27. Lin, Z.B.: Pharmacological activities of Lingzhi. In Z.B. Lin (Ed.), Modern Research of Ganoderma lucidum, second ed., Beijing Medical University Press, Beijing, pp. 219-283, 2001.
28. Leung, S.W.S., Yeung, K.Y., Siow Ricky, Y.L., Man, Y.K.: Lingzhi (Ganoderma) research - the past, present and future perspectives. In Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Z.B. Lin (Ed.), Proc. Int. Symp. Ganoderm Research, October 21-23, 2002, Shanghai, China, Beijing Medical University Press, pp. 1-9, 2002.
29. Lei, L.S. and Lin, Z.B.: Antagonistic effect of Ganoderma lucidum polysaccharides on the immunosuppressive response induced by cyclosporine A, hydrocortisone and antitumor agents. Chin. J. Pharmacol. and Toxicol., 7, 183-185, 1993.
30. Miyazaki, T. and Nishijima, M.: Studies on fungal polysaccharides. XXVII. Structural examination of water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem. Pharm. Bull., 29 (12), 3611-3616, 1981.
31. Fang, J.N., Bao, X.F. and Yuan, W.H.: Studies on the polysaccharides from spores of Ganoderma lucidum. In Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Z.B. Lin (Ed.), Proc. Int. Symp. Ganoderma Research, October 21-23, 2002, Shanghai, China, Beijing Medical University Press, pp. 98-103, 2002.
32. Tomoda, M., Gonda, R., Kasahara, Y., Hikino, H.: Glycan structures of ganoderrans B and C, hypoglycemic glycans of Ganodrama lucidum fruit bodies. Phytochemistry 25 (12), 2817-2820, 1986.
33. Cao, L.Z. and Lin, Z.B.: Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immun. Lett., 83, 163-169, 2002.
34. Cao, L.Z. and Lin, Z.B.: Regulatory effect of ganodrma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta Pharmacol. Sin., 24 (4), 321-326, 2003.
35. Zhou, G.Y., Jiang, S., Huang, M., Dai, X.: Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol. Invest., 32 (3), 201-215, 2003.
36. Okui, Y., Morita, M., Iizuka, A., Komatsu, Y., Okada, M., Maruno, M.: Effects of Hoelen on the efferent activity of the gastric vagus nerve in the rat. Jpn. J. Pharmacol., 72 (1), 71-73, 1996.
37. Lee, C.J., Koizumi, K., Koizumi, M., Aburada, M.: Immunomodulating effects of polysaccharides isolated from herbal products. J. Trad. Med., 16, 175-182, 1999.
38. Miyazaki, T., Oikawa, N., Yamada, H., Yadomae, T.: Structural examination of antitumour, water-soluble glucoans from Grifora umbellate by use of four types of glucanase. Carbohy. Res., 65, 235-243, 1978.
39. Yamada, H., Kawaguchi, N., Ohmori, T., Takeshita, Y., Taneya, S.T., Miyazaki, T.: Structure and antitumor activity of an alkali-soluble polysaccharide from Cordyceps ophioglossoides. Carboh. Res., 125, 107-115, 1984.
40. Ukai, S., Matsuura, S., Hara, C., Kiho, T., Hirose, K.: Structure of a new galactomannan from the ascocarps of Cordyceps cidadae. Carbohy. Res., 101, 109-116, 1982.
41. Misaki, A., Kakuta, M., Sasaki, T., Tanaka, M., Miyaji, H.: Studies on interrelation of structure and antitumor effects of polysaccharides: antitumor action of periodate-modified, branched (1-3)-β-D-glucan of Auricularia auricula-judae, and other polysachharides containing (1-3)-glycosidic linkages. Carbohy. Res., 92, 115-129, 1981.
42. Kiho, T., Shiose, Y., Nagai, K., Ukai, S.: Polysaccharides in fungi. XXX. Anti-tumor and immunomodulating activities of two polysaccharides from the fruiting bodies of Armillariella tabescens. Chem. Pharm. Bull. (Tokyo), 40, 2110-2114, 1992.
43. Miyazaki, T., and Nishijima, M.: Studies of fungal polysaccharides. XXVI. An alkali-soluble glucan of Omphalia lepidescence. Chem. Pharm. Bull., 28, 3118-3121, 1980.
44. Ukai, S., Kiko, T., Hara, C.: Polysaccharides in fungi. XIII. Antitumor activity of various polysaccharides isolated from Dictyophora indusiata, Ganoderm japonicum, Cordyceps cicadae, Auricularia auricular-judae, and Auricularia series. Chem. Pharm. Bull., 31, 741-744, 1983.
45. Whistler, R.L., Bushway, A.A. and Singh, P.P.: Noncytotoxic, antitumor polysaccharides. Adv. Carbohyd. Chem. and Biochem., 32, 235-275, 1976.
46. Tang, W., Hemm, I. and Bertram, B.: Recent development of antitumor agents from Chinese herbal medicines. Part II. High molecular compounds. Planta Med., 69, 193-201, 2003.
47. Tomoda, M., Shimizu, N., Ohara, N., Gonad, R., Ishi, S., Otsuki, H.: A reticuloendothelial system-activating glycan from the roots of Astragalus membranaceus. Phytochemistry 31, 63-66, 1991.
48. Zheng, Z., Liu, D., Song, C., Chong, C., Hu, Z.: Studies on chemical constituents and immunological function activity of hairy root of Astragalus membranaceus. Chin J. Biotechnol., 14 (2), 93-97, 1998.
49. Shimizu, N., Tomoda, M., Kanari, M., Gonda, R.: An acidic polysaccharide having activity on the reticuloendothelial system from the root of Astragalus mongholicus. Chem. Pharm. Bull. (Tokyo), 39, 2969-2972, 1991.
50. Tu, W.W., Yang, Y.Q., Wang, L.J., Zhang, Y.W. Shen, J.: In vivo effects of Astragalus membranaceus on immunoglobulin G subclass deficiency. Chin J. Immunol., 11, 34-37, 1995.
51. Chu, D.T., Wong, W.L., Mavligit, G.M.: Immunotherapy with Chinese medicinal herb. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranadeus in vivo. J. Chin. Lab. Immunol., 25, 125-129, 1988.
52. Zhao, K.W. and Kong, H.Y.: Effect of astragalan on secretion of tumor necrosis factors in human peripheral blood mononuclear cells. Chin. J. Integr. Trad. West Med., 13, 263-265, 1993.
53. Lau, B.H., Ruckle, H.C., Botolazzo, T., Lui, P.D.: Chinese medicinal herbs inhibit growth of murine renal cell carcinoma. Cancer Biother., 9, 153-161, 1994.
54. Yoshida, Y., Wang, M.Q., Liu, J.N., Shan, B.E., Yamashita, U.: Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int. J. Immunopharmac., 19 (7), 359-370, 1997.
55. Cho, C.H., Mei, Q.B., Shang, P., Lee, S.S., So, H.L., Guo, X., Li, Y.: Study of the gastrointestinal protective effects of polysaccharides from Angelica sinensis in rats. Planta Med., 66, 348-351, 2000.
56. Ye, Y.N., Koo, M.W.L., Li, Y., Matsui, H., Cho, C.H.: Angelica sinensis modulates migration and proliferation of gastric epithelial cells. Life Sci., 68, 961-968, 2001.
57. Ye, Y.N., So, H.L., Liu, E.S.L., Shin, V.Y., Cho, C.H.: Effect of polysaccharides from Angelica sinensis on gastric ulcer healing. Life Sci., 72, 925-932, 2003.
58. Kumazawa, Y., Mizunoe, K., and Otsuka, Y. : Immunostimulating polysaccharide separated from hot water extract of Angelica acutiloba Kitagawa (Yamato Tohki). Immunology 47, 75-83, 1982.
59. Yamada, H., Kiyohara, H., Cyong, J.C., Kojima, Y., Kumazawa, Y., Otsuka, Y.: Studies on polysaccharides from Angelica acutiloba. Planta Med., 50, 163-167, 1984.
60. Yamada, H., Komiyama, K., Kiyohara, H., Cyong, J.C., Hirakawa, Y., Otsuka, Y.: Structural characterization and antitumor activity of a pectic polysaccharide from the roots of angelica acutiloba. Planta Med., 56, 182-186, 1990.
61. Ye, Y.N., Liu, E.S.L., Li, Y., So, H.L., Cho, C.C.M., Sheng, H.P., Lee, S.S., Cho, C.H.: Protective effect of polysaccharide-enriched fraction from Angelica sinensis on hepatic injury. Life Sci., 69, 637-646, 2001.
62. Han, S.B., Kim, Y.H., Lee, C.W., Park, S.M., Lee, H.Y., Ahn, K.S., Kim, I.H., Kim, H.M.: Characteristic immunostimulation by angelan isolated from angelica gigas Nakai. Immunopharmacology 40, 39-48, 1998.
63. Ahn, K.S., Sim, W.S., Kim, H.M., Han, S.B., Kim, I.H.: Immunostimulating polysaccharide from cell culture of Angelica gigas Nakai. Biotechnol. Lett., 20 (1), 5-7, 1998.
64. Jeon, Y.J., Han, S.B., Ahn, K.S., Kim, H.M.: Differential activation of murine macrophage by angelan and LPS. Immunopharmcol., 49, 275-284, 2000.
65. Jeon, Y.J., Han, S.B., Lee, S.H., Kim, H.C., Ahn, K.S., Kim, H.M.: Activation of mitogen-activated protein kinase pathways by angelan in murine macrophages. Int. Immunopharmacol., 1, 237-245, 2001.
66. Wang, B.X.: Progress of pharmacological studies on ginseng. Acta Pgarmaceut. Sin., 15, 312-320, 1980.
67. Liu, C.X., Xiao, P.G. : Recent advances on ginseng research in China. J. Ethnopharmacology 36, 27-38, 1992.
68. Yun, Y.S., Lee, Y.S., Jo, S.K., Jung, I.S.: Inhibition of autochthonous tumor by ethanol insoluble fraction from Panax ginseng as immunomodulator. Planta Med., 59, 521-524, 1993.
69. Lee, Y.S., Chung, I.S., Lee, I.R., Kim, K.W., Hong, W.S.: Activation of multiple effectors pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res., 17, 323-332, 1997.
70. Kim, K.H., Lee, Y.S., Jung, I.S., Park, S.Y., Chung, H.Y., Lee, I.R., Yun, Y.S.: Acidic polysaccharide from Panax ginseng, Ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Med., 64, 110-115, 1998.
71. Shin, J.Y., Song, J.Y., Yun, Y.S., Yang, H.D., Rhee, D.K., Pyo, S.: Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol. Immunotoxicol., 24 (3), 469-482, 2002.
72. Song, J.Y., Han, S.K., Son, E.H., Pyo, S.N., Yun, Y.S., Yi, S.Y.: Induction of secretory and tumoricidal activities in peritoneal macrophages by ginsan. Int. Immunopharmacol., 2, 857-865, 2002.
73. Friedl, R., Moeslinger, T., Kopp, B., Spieckermann, P.G.: Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells. Br. J. Pharmacol., 134, 1663-1670, 2001.
74. Lim, D.S., Bae, K.G., Jung, I.S., Kim, C.H., Yun, Y.S., Song, J.Y.: Anti-septicaemic effect of polysaccharide from Panax ginseng by macrophage activation. J. Infect., 45, 32-38, 2002.
75. Lien, E.J., Das, A. and Lien, L.L.: Immunopharmacological and biochemical bases of Chinese herbal medicine. Prog. Drug Res., 46, 263-280, 1996.
76. Bao, X., Liu, C., Fang, J., Li, X.Y.: Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohyd. Res., 332, 67-74, 2001.
77. Bao, X., Duan, J., Fang, X., Fang, J.: Chemical modifications of the (1-3)-α-D-glucan from spores of Ganoderma lucidum and investigation of their physicochemical properties and immunological activity. Carbohyd. Res., 336, 127-140, 2001.
78. Cong, Z.: The pharmacological study of Lingzhi and the research of the therapeutic principle of Fuzheng Guben in traditional Chinese Medicine. In Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Z.B. Lin (Ed.), Proc. Int. Symp. Ganoderma Research, October 21-23, 2002, Shanghai, China, Beijing Medical University Press, pp. 35-38, 2002.
79. Lin, Z.B. : Clinical application of Lingzhi. In Z.B. Lin (Ed.), Modern Research of Ganoderma lucidum, second ed., Beijing Medical University Press, Beijing, pp. 284-309, 2001.
80. Lee, S.S., Wei, Y.H., Chen, C.F., Wang, S.Y., Chen, K.Y.: Antineoplastic effects of Ganoderma lucidum. J. Chin. Med., 6, 1-12, 1995.
81. Xiao, P.G., Xing, S.T., Wang, L.W.: Immunological aspects of Chinese medicinal plants as antiaging drugs. J. Ethnopharmacol., 38, 167-175, 1993.
82. Clien, K.J., Zhaiig, W.P.: Advances on antiaging herbal medicine in China. Abstracts of Chinese Med., 1(2), 309-330, 1987.
83. Zhang, L.H., Xiao, P.G.: Inhibitory actions of Ganoderma lucidum spore extract on delayed-type hypersensitivity in mice. Phytother. Res., 7, 203-204, 1993.
84. Yamada, H.: The role of bioactive polysaccharides in Kampo medicines. In Pharmacological Research on traditional Herbal Medicines, Watanabe, H. and Shibuya T. (Eds.), Harwood Academic Publishers, Amsterdam, The Netherlands pp. 179-196, 1999.
85. Wood, A.J.J., Smet, P.: Herbal remedies. N. Engl. J. Med., 347, 2047-2056, 2002.
86. Mitscher, L.A., Pillai, S., Shankel, D.M.: Some transpacific thoughts on the regulatory need for standardization of herbal medical products. J. Food Drug Anal., 8 (4), 229-234, 2000.
87. Center for Drug Evaluation and Research.: Guidance for industry botanical drug products. CDER, Food and Drug Administration, Rockville, MD, 1-48, 2001.
88. Wu, K. M., Degeorge, J.G., Atrakchi, A., Barry, E., Bigger, A., Chen, C., Du, T., Freed, L., Geyer, H., Goheer, A., Jacob, A., Jean, D., Rhee, H., Osterberg, R., Schmidt, W., Farrelly, J.G. : Regulatory science: a special update from the United States Food and Drug Administration, preclinical issues and status of investigation of botanical drug products in the United States. Toxicol. Let., 111, 199-202, 2000.
89. Chan, K. : Linking chemical and biological characteristics in assuring the quality of Chinese medicinal materials and OTC products. In Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Z.B. Lin (Ed.), Proc. Int. Symp. Ganoderma Research, October 21-23, 2002, Shanghei, China, Beijing Medical University Press, pp. 24-34, 2002.
90. Yeung, H. W., Lu, Q.Y., Zhang, Q.F., Go, V.L.W.: Chemical and biochemical basis of the anti-tumor properties of Ganoderma lucidum. In Ganoderma: Genetics, Chemistry, Pharmacology and therapeutics, Z.B. Lin (Ed.), Proc. Int. Symp. Ganoderma Research, October 203, 2002, Shanghei, China, Beijing Medical University Press, pp. 203, 2002.
91. Lin, Y.: Modernization of Chinese herbal medicine through scientific and clinical validations. J. Food and Drug Anal., 5 (4), 235-240, 1997.
92. Lee, K.H.: Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr., 3, 515-522, 2000.
93. Tyler, V.E.: Phytomedicines: Back to the future. J. Nat. Prod., 62, 1589-1592, 1999.
94. Lee, K.H.: Scientific Chinese herbal medicine: Research and movement toward worldwide acceptance. J. Food Drug Anal., 5, 233-234, 1997.
95. Sasaki, T. and Takashuka, N.: Further study of the structure of Lentinan, an anti-tumor polysaccharide from Lentinus edodes. Carbohy. Res., 47, 99-104, 1976.
96. Hamuro, I., Yamashita, Y., Ohsaka, Y., Maeda, Y.Y., Chihara, G.: Carboxymethyl pachymaran, a new soluble polysaccharide with marked antitumor activity. Nature 233, 486-487, 1971.
97. Miyazaki, T., Yadomae, T., Yamada, H., Yamada, Y., Hsu, H. Y., Ito, H.: Relationship between the chemical structure and anti-tumor activity of glucans prepared from Griford umbellate. Carbohy. Res., 69, 165-170, 1979.
98. Ueno, Y., Abe, M., Yamauchi, R., Kato, K.: Structural analysis of the alkali-soluble polysaccharide from the Sclerotia of Grifora umbellate. Carbohy. Res., 87, 257-264, 1980.
99. Whistler, R.L., Bushway, A.A., Singh, P.P.: Noncytotoxic, antitumor polysaccharides. Adv. Carbohy. Chem. and Biochem., 32, 235-275, 1976.
100. Shin, K.H., Lim, S.S., Lee, S.H., Lee, Y.S., Cho, S.Y.: Antioxidant and immunostimulating activities of the fruiting bodies of Paecilomyces japonica, a new type of Cordyceps sp. Ann. N.Y. Acad. Sci., 928, 261-273, 2001.
101. Ukai, S., Matsuura, S., Hara, C., Kiho, T., Hirose, K.: Structure of a new galactomannan from the ascocarps of Cordyceps cicadae. Carbohy. Res., 101, 109-116, 1976.
102. Haranaka, K., Satomi, N., Sakurai, A., Haranaka, R., Okada, N., Kobayashi, M.: Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol. Immunother., 20 (1), 1-5, 1985.
103. Du, S.Y. and Qian, Y.K.: Effect of extract of Lycium barbarum on the IL-2R expression of human lymphocytes. Chin. J. Microbiol. Immunol., 15, 176-178, 1995.
104. Geng, C.S., Xing, S.T., Zhou, J.H., Chu, B.M.: Enhancing effect of Lycium barbarum polysaccharides on the interleukin-2 activity in mice. Chin. J. Pharmacol. Toxicol., 3, 175-179, 1989.
105. Zhang, X., Li, J., Liang, H.B., Wang, L., Qian, Y.K.: Effects of Lycium barbarum polysaccharide on the cell membrane fruidity and protein kinase C in vitro. J. Beijing Med. Univ., 29, 118-120, 1997.
106. Liu, J.L., Zhang, L.H. and Qian, Y.K. : Tumor inhibition of Lycium barbarum polysaccharide on S180-bearing mice. Chin. J. Immunol., 12, 115-117, 1996.
107. Shan, B.E., Yoshida, Y., Sugiura, T., Yamashita, U.: Stimulating activity of Chinese Medicinal herbs on human lymphocytes in vitro. Int. J. Immunopharmacol., 21, 149-159, 1999.
108. Zeng, X.L., Li, X.A. and Zhang, B.Y.: Immunological and hematopoietic effect of Codonopsis pilosula on cancer patients during radiotherapy. Chin. J. Integr. Trad. West. Med., 12, 607-608, 1992.
109. Shen, M.L., Zhai, S.K., Chen, H.L., Luo, Y.D., Tu, G.D., Ou, D.W.: Immunopharmacological effects of polysaccharides from Acanthopanax senticosus on experimental animals. Int. J. Immunolpharm., 13, 549-554, 1991.
110. Wang, J.Z., Tsumura, H., Shimura, K., Ito, H.: Antitumor activity of polysaccharide from Chinese medicinal herb, Acanthopanax giraldii. Cancer Letters 65, 79-84, 1992.
111. Wang, J.Z., Mao, X.J. Ito, H., Shimura, K.: Immunomodulatory activity of polysaccharide from Acanthopanax oboratus roots. Planta Medica 57, 335-336, 1991.
112. Miyanomae, T. and Frindel, E. : Radioprotection of hemopoiesis conferred by Acomthopanax senticosus Harms (Shigoka) administered before and after irradiation. Exptl. Haematol., 16, 801-806, 1988.